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Background: The morphological assessment of neointimal tissue is highly significant to clarify the pathophysiology of in-stent restenosis (ISR) 
after drug-eluting stent (DES) implantation. Recently, the assessments of in-stent restenotic tissue using optical coherence tomography (OCT) were 
performed and the differences of morphological characteristics among various DESs were reported. However, little was known about the restenotic 
tissue characteristics after everolimus-eluting stent (EES) and zotarolimus-eluting stent (ZES) implantation. In this study, we clarify the difference 
between the restenotic tissue characteristics after EES implantation and those after ZES implantation.
Methods: Between February 2008 and April 2011, we assessed in-stent restenosis lesions after EES implantation in 14 patients and those after 
ZES in 16 patients using OCT. The morphological assessment of neointimal tissue at the minimum lumen area site by OCT, including restenotic tissue 
structure (homogeneous, heterogeneous, and layered type), restenotic tissue backscatter, visible microvessels, lumen shape, and the presence of 
intraluminal material, was performed.
Results: The patients were 25 men and 5 women, and the mean age was 67.1±10.5 years. Homogeneous intima was observed more frequently in 
lesions with EES than in those with ZES (78.6% vs. 31.3%, p<0.05), while layered intima was observed more frequently in lesions with ZES than in 
those with EES (68.8% vs. 21.4%, p<0.05). Heterogeneous intima was not found in both groups. Intraluminal material was more frequently observed 
in lesions with EES than in those with ZES (28.6% vs. 0%, p<0.05). Microvessels tended to be frequently observed in lesions with ZES than those with 
EES (37.5% vs. 7.1%, p=0.086).
Conclusions: The pathophysiology of in-stent restenosis after EES implantation might be different from that after ZES.
